Teva Pharmaceutical Industries Limited (FRA:TEV)

FRA:TEV Statistics

Total Valuation

FRA:TEV has a market cap or net worth of EUR 18.03 billion. The enterprise value is 31.18 billion.

Market Cap	18.03B
Enterprise Value	31.18B

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.25%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.14B

Valuation Ratios

PE Ratio	n/a
Forward PE	7.13
PS Ratio	1.27
PB Ratio	3.10
P/TBV Ratio	n/a
P/FCF Ratio	23.79
P/OCF Ratio	15.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.81, with an EV/FCF ratio of 41.14.

EV / Earnings	-233.24
EV / Sales	2.19
EV / EBITDA	7.81
EV / EBIT	10.41
EV / FCF	41.14

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 2.57.

Current Ratio	1.06
Quick Ratio	0.48
Debt / Equity	2.57
Debt / EBITDA	3.76
Debt / FCF	19.71
Interest Coverage	3.59

Financial Efficiency

Return on equity (ROE) is -2.42% and return on invested capital (ROIC) is 8.77%.

Return on Equity (ROE)	-2.42%
Return on Assets (ROA)	5.37%
Return on Invested Capital (ROIC)	8.77%
Return on Capital Employed (ROCE)	12.38%
Revenue Per Employee	382,669
Profits Per Employee	-3,613
Employee Count	35,686
Asset Turnover	0.41
Inventory Turnover	2.26

Taxes

In the past 12 months, FRA:TEV has paid 80.04 million in taxes.

Income Tax	80.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.85%
50-Day Moving Average	14.38
200-Day Moving Average	15.61
Relative Strength Index (RSI)	59.55
Average Volume (20 Days)	1,444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.08

Income Statement

In the last 12 months, FRA:TEV had revenue of EUR 14.16 billion and -133.69 million in losses. Loss per share was -0.12.

Revenue	14.16B
Gross Profit	7.02B
Operating Income	2.98B
Pretax Income	-57.90M
Net Income	-133.69M
EBITDA	3.85B
EBIT	2.98B
Loss Per Share	-0.12

Balance Sheet

The company has 1.84 billion in cash and 14.94 billion in debt, giving a net cash position of -13.10 billion.

Cash & Cash Equivalents	1.84B
Total Debt	14.94B
Net Cash	-13.10B
Net Cash Per Share	n/a
Equity (Book Value)	5.82B
Book Value Per Share	5.07
Working Capital	646.29M

Cash Flow

In the last 12 months, operating cash flow was 1.18 billion and capital expenditures -425.75 million, giving a free cash flow of 757.84 million.

Operating Cash Flow	1.18B
Capital Expenditures	-425.75M
Free Cash Flow	757.84M
FCF Per Share	n/a

Margins

Gross margin is 49.60%, with operating and profit margins of 21.05% and -0.94%.

Gross Margin	49.60%
Operating Margin	21.05%
Pretax Margin	-0.41%
Profit Margin	-0.94%
EBITDA Margin	27.20%
EBIT Margin	21.05%
FCF Margin	5.35%

Dividends & Yields

FRA:TEV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.25%
Shareholder Yield	n/a
Earnings Yield	-0.74%
FCF Yield	4.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:TEV has an Altman Z-Score of 0.57 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.57
Piotroski F-Score	6